Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
7.05
-0.16 (-2.22%)
May 21, 2026, 3:04 PM CST
SHE:300636 Revenue
Jiangxi Synergy Pharmaceutical had revenue of 184.39M CNY in the quarter ending March 31, 2026, a decrease of -1.34%. This brings the company's revenue in the last twelve months to 826.15M, up 11.74% year-over-year. In the year 2025, Jiangxi Synergy Pharmaceutical had annual revenue of 828.66M with 9.19% growth.
Revenue (ttm)
826.15M
Revenue Growth
+11.74%
P/S Ratio
3.58
Revenue / Employee
582.62K
Employees
1,418
Market Cap
2.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 828.66M | 69.77M | 9.19% |
| Dec 31, 2024 | 758.89M | 36.75M | 5.09% |
| Dec 31, 2023 | 722.14M | 2.23M | 0.31% |
| Jan 1, 2023 | 719.91M | 127.78M | 21.58% |
| Dec 31, 2021 | 592.13M | 156.71M | 35.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.86B |
| Guizhou Yibai Pharmaceutical | 1.72B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.11B |
| Anhui Sunhere Pharmaceutical Excipients | 956.32M |
| Zhejiang Shengda Bio-Pharm | 830.53M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 747.80M |
| Hainan Huluwa Pharmaceutical Group | 710.14M |
| Honz Pharmaceutical | 466.12M |